Gish enVisions hitting $10 mil. in annual hollow fiber oxygenator sales in 18-24 months.
This article was originally published in The Gray Sheet
Executive Summary
GISH ENVISIONS REACHING $10 MIL. HOLLOW FIBER OXYGENATOR ANNUAL SALES LEVEL in 18-24 months, the firm states. Gish began full-scale marketing of the Vision oxygenator, used to replace the function of the lungs during open-heart surgery, Jan. 26 at the Society of Thoracic Surgeons meeting in New Orleans. As Gish Biomedical's first oxygenator, the Vision completes the company's cardiovascular heart/lung bypass circuit offerings. The device lists for $400 alone, or $450 with a hard shell venous reservoir.